EARLY CANCER DIAGNOSTICS BY REVOLUTIONARY METHOD
Unique VOC technology combined with machine learning enables, in its simplicity, early detection of ovarian cancer through smell in a blood sample.
SOLUTION
We are further developing our product and collecting clinical evidence to obtain regulatory approval in the European market targeted to be introduced to the market 2029.
ADVANCING CANCER DIAGNOSTICS
Our mission is to enable a paradigm shift in early diagnosis of ovarian cancer through unmatched performance regarding sensitivity and specificity.
UNIQUE SOLUTION
VOC Diagnostics has developed a unique detection method by analyzing volatile organic compounds from blood plasma samples to detect ovarian cancer with higher accuracy than any other available method.
